Finance

Beta
Lists
ACXP:NASDAQ
Acurx Pharmaceuticals Inc
$1.68
-5.08%
(-0.090) 1D
$1.60
-4.76% (-0.080)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACXP...
Open
$1.77
High
$1.78
Low
$1.62
Mkt. cap
7.22M
Avg. vol.
120.19K
Volume
96.96K
52-wk high
$21.00
52-wk low
$1.33
EPS
-$4.46
Beta
-2.09
Shares outstanding
4.30M
No. of employees
4
Open
$1.77
High
$1.78
Low
$1.62
Mkt. cap
7.22M
Avg. vol.
120.19K
Volume
96.96K
52-wk high
$21.00
52-wk low
$1.33
EPS
-$4.46
Beta
-2.09
Shares outstanding
4.30M
No. of employees
4
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to ACXP in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ACXP in the last 3 months.
Highest
Current $1.68
$31.00 (+1,745.24%)
Average
$17.00 (+911.90%)
Lowest
$10.00 (+495.24%)
News stories
From sources across the web
About Acurx Pharmaceuticals Inc
CEODavid P Luci
Employees4
Founded2017
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
524.21K
429.69K
281.81K
341.47K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.75M
1.60M
1.34M
1.37M
Operating expense
2.27M
2.03M
1.62M
1.72M
Total operating expenses
2.27M
2.03M
1.62M
1.72M
Operating income
-2.27M
-2.03M
-1.62M
-1.72M
Other non operating income
-
-
-
-
EBT including unusual items
-2.25M
-1.99M
-1.58M
-1.68M
EBT excluding unusual items
-2.25M
-1.99M
-1.58M
-1.68M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.25M
-1.99M
-1.58M
-1.68M
Net profit margin
-
-
-
-
Earnings per share
-1.89
-1.23
-0.31
-0.62
Interest and investment income
23.40K
35.91K
38.84K
35.01K
Interest expense
-
-
-
-
Net interest expenses
23.40K
35.91K
38.84K
35.01K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more